RegWardenFDA facility compliance records
Facility

Beijing Target Medical Technologies Inc.

1 recall(s) on record — most severe on record: Class I.

Activity by year

FDA actions on record by year2016: 1 inspections; 2021: 1 recalls1201620172018201920201202120222023202420252026
  • Recalls (1)
  • Inspections (1)

Devices registered here (1)

  • Syringe, Balloon Inflation, Exempt
    Product code PTM (opens in a new tab) · Class II · Cardiovascular · 21 CFR 870.1650

Recalls & enforcement

  • Class ICompleted2021-04-26
    Leccurate SARS-CoV-2, Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) is not authorized, cleared, or approved for marketing and/or distribution in the U.S.

FDA inspections (1)

  • NAI2016-05-25
    No Action Indicated · Compliance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Beijing Target Medical Technologies Inc. (FEI 3011564431) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3011564431-beijing-target-medical-technologies-inc/

Not open yet

Alerts for Beijing Target Medical Technologies Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.